Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Mayo Clinic Arizona, Phoenix, Arizona HonorHealth Research and Innovation Institute, Scottsdale, Arizona Mayo Clinic Florida, Jacksonville, Florida Mayo Clinic Rochester, Rochester, Minnesota